HALIFAX, Oct. 19  - MedMira Inc., ("MedMira") announced today that it has received 
US Food and Drug Administration (FDA) approval for its Reveal(R) G3 Rapid
HIV-1 Antibody Test (Reveal G3). Reveal G3, which delivers test results in
less than three minutes, is the third generation in the Reveal line of
rapid HIV tests. Previous versions of the product were approved by the FDA
in 2003 and 2004.

Reveal G3 includes the addition of MedMira's InstantGold(TM) Cap which
replaces the colorimetric detection agent used to visualize results on the
test cartridge. This advancement eliminates the need for reconstitution and
refrigeration of the colorimetric detection agent, improving the product's
overall ease-of-use. MedMira now offers Reveal G3 in a box of 30, a new
size format designed to maximize efficiency of all components included in
the test package.